TwitterLinkedinWhatsAppTelegramTelegram
0
Read this article in:

The Commission gives a 5-year period for withdrawing zinc oxide for piglets

The Commission considers that the Member States must be given a 5-year period for withdrawing the marketing authorisations of veterinary drugs that contain zinc oxide.

27 June 2017
TwitterLinkedinWhatsAppTelegramTelegram
0

The European Commission has finally decided to forbid the use of veterinary drugs that contain zinc oxide.

According to the draft of the Decision, the Commission has decided to withdraw the marketing authorisations and to deny new authorisation requests for the commercialisation of zinc oxide for its use in piglets. The Commission consulted the Member States and stakeholders, which presented their views on the potential adverse impact stemming from the immediate withdrawal of the marketing authorisations in certain Member States. While recognising that the environmental impact depended on the soil type, it is necessary to allow time to develop alternatives that are available and affordable and change pig farming practices without increasing the use of antimicrobials. Therefore, the Commission considers that the Member States must be granted a 5-year period to withdraw the marketing authorisations of veterinary drugs containing zinc oxide.

Background

The matter had been referred to the Committee by the Netherlands and France under Article 35 of Directive 2001/82/EC due to concerns related to the potential risk to the environment and the increase of the prevalence of antibiotic-resistant bacteria from the use of products containing zinc oxide. The Committee concluded that overall, the benefit-risk balance for the products concerned by this referral is negative, as the benefits of zinc oxide for the prevention of diarrhoea in pigs do not outweigh the risks for the environment. The CVMP acknowledged that there is a risk of co-selection for resistance associated with the use of zinc oxide, but that at present such risk is not quantifiable. The Committee adopted by consensus a final opinion recommending the refusal of the granting of the marketing authorisations and the withdrawal of the existing marketing authorisations for veterinary medicinal products containing zinc oxide.

Last March, the CVMP re-examined the case, concluding that the recommendations included in its initial judgement from December 2016 should be maintained, and left on the hands of the European Commission the final decision about these products.

Monday, 19 June 2017/ Comitology Register/ European Commission.
http://ec.europa.eu/transparency/regcomitology

Article Comments

This area is not intended to be a place to consult authors about their articles, but rather a place for open discussion among pig333.com users.
Leave a new Comment

Access restricted to 333 users. In order to post a comment you must be logged in.

Related products in the shop

The shop specialized in the pig sector
Advice and technical service
More than 120 brands and manufacturers

Related articles

Swine News

Swine industry news in your email

You are not subscribed to this list

Log in and sign up on the list